These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8581374)

  • 21. Molecular applications of fusions to leucine zippers.
    Rieker JD; Hu JC
    Methods Enzymol; 2000; 328():282-96. PubMed ID: 11075351
    [No Abstract]   [Full Text] [Related]  

  • 22. Bispecific F (ab')2 monomer prepared with anti-CD3 and anti-tumor monoclonal antibodies is most potent in induction of cytolysis of human T cells.
    Nitta T; Yagita H; Azuma T; Sato K; Okumura K
    Eur J Immunol; 1989 Aug; 19(8):1437-41. PubMed ID: 2528460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trispecific F(ab')3 derivatives that use cooperative signaling via the TCR/CD3 complex and CD2 to activate and redirect resting cytotoxic T cells.
    Tutt A; Stevenson GT; Glennie MJ
    J Immunol; 1991 Jul; 147(1):60-9. PubMed ID: 1675655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transformation by Jun: requirement for leucine zipper, basic region and transactivation domain and enhancement by Fos.
    Morgan IM; Ransone LJ; Bos TJ; Verma IM; Vogt PK
    Oncogene; 1992 Jun; 7(6):1119-25. PubMed ID: 1594243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional dissection of AP-1 transcription factors using the Gal4 adaptor assay.
    Smith SE; Bohmann D
    Cell Growth Differ; 1992 Aug; 3(8):523-9. PubMed ID: 1390338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Jun and Fos heterodimerize with ATFa, a member of the ATF/CREB family and modulate its transcriptional activity.
    Chatton B; Bocco JL; Goetz J; Gaire M; Lutz Y; Kedinger C
    Oncogene; 1994 Feb; 9(2):375-85. PubMed ID: 8290251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The sensitivity of c-Jun and c-Fos proteins to calpains depends on conformational determinants of the monomers and not on formation of dimers.
    Pariat M; Salvat C; Bébien M; Brockly F; Altieri E; Carillo S; Jariel-Encontre I; Piechaczyk M
    Biochem J; 2000 Jan; 345 Pt 1(Pt 1):129-38. PubMed ID: 10600648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos.
    Echlin DR; Tae HJ; Mitin N; Taparowsky EJ
    Oncogene; 2000 Mar; 19(14):1752-63. PubMed ID: 10777209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crystal structure of the heterodimeric bZIP transcription factor c-Fos-c-Jun bound to DNA.
    Glover JN; Harrison SC
    Nature; 1995 Jan; 373(6511):257-61. PubMed ID: 7816143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Encounters with Fos and Jun on the road to AP-1.
    Abate C; Curran T
    Semin Cancer Biol; 1990 Feb; 1(1):19-26. PubMed ID: 2133107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thermodynamic analysis of the heterodimerization of leucine zippers of Jun and Fos transcription factors.
    Seldeen KL; McDonald CB; Deegan BJ; Farooq A
    Biochem Biophys Res Commun; 2008 Oct; 375(4):634-8. PubMed ID: 18725194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Jun DNA-binding is modulated by mutations between the leucines or by direct interaction of fos with the TGACTCA sequence.
    Hirai S; Yaniv M
    New Biol; 1989 Nov; 1(2):181-91. PubMed ID: 2562220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natural antibodies against the immunoglobulin F(ab')2 fragment cause elimination of antigens recognized by the F(ab')2 from the circulation.
    Yano S; Kaku S; Suzuki K; Terazaki C; Sakayori T; Kawasaki T; Kawamura K; Sugita Y; Hoshino K; Masuho Y
    Eur J Immunol; 1995 Nov; 25(11):3128-33. PubMed ID: 7489753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transformation by Fos proteins requires a C-terminal transactivation domain.
    Wisdon R; Verma IM
    Mol Cell Biol; 1993 Dec; 13(12):7429-38. PubMed ID: 7504176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of c-Fos and c-Jun redox-dependent DNA binding activity.
    Xanthoudakis S; Curran T
    Methods Enzymol; 1994; 234():163-74. PubMed ID: 7808290
    [No Abstract]   [Full Text] [Related]  

  • 36. Valency of CD3 binding and internalization of the CD3 cell-surface complex control T cell responses to second signals: distinction between effects on protein kinase C, cytoplasmic free calcium, and proliferation.
    Ledbetter JA; June CH; Martin PJ; Spooner CE; Hansen JA; Meier KE
    J Immunol; 1986 Jun; 136(11):3945-52. PubMed ID: 3084650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ds-Oligonucleotide-peptide conjugates featuring peptides from the leucine-zipper region of Fos as switchable receptors for the oncoprotein Jun.
    Portela C; Albericio F; Eritja R; Castedo L; Mascareñas JL
    Chembiochem; 2007 Jul; 8(10):1110-4. PubMed ID: 17516573
    [No Abstract]   [Full Text] [Related]  

  • 38. Synthesis of bifunctional antibodies for immunoassays.
    DeSilva BS; Wilson GS
    Methods; 2000 Sep; 22(1):33-43. PubMed ID: 11020315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Forcing interactions as a genetic screen to identify proteins that exert a defined activity.
    Devit M; Cullen PJ; Branson M; Sprague GF; Fields S
    Genome Res; 2005 Apr; 15(4):560-5. PubMed ID: 15805496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bispecific rabbit Fab'-bovine serum albumin conjugate used in hemagglutination immunoassay for beta-microseminoprotein.
    Yukawa N; Osawa M; Saito T; Hasegawa T; Matsuda H; Takahama K; Takeichi S
    J Immunoassay; 1997 Aug; 18(3):215-33. PubMed ID: 9257262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.